Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-050670

CFO & Executive Vice President acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dier Mardi · CFO & Executive Vice President

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-09-16 Grant or award : show line 1 in the form +20,000 71,808 D
Loading xslF345X03/doc4.xml…